vs
Avantor, Inc.（AVTR）与Rocket Companies, Inc.（RKT）财务数据对比。点击上方公司名可切换其他公司
Rocket Companies, Inc.的季度营收约是Avantor, Inc.的1.6倍（$2.7B vs $1.7B），Avantor, Inc.净利率更高（3.1% vs 2.5%，领先0.6%），Rocket Companies, Inc.同比增速更快（52.2% vs -1.4%），Avantor, Inc.自由现金流更多（$117.2M vs $-1.3B），过去两年Rocket Companies, Inc.的营收复合增速更高（39.5% vs -0.5%）
Avantor是一家总部位于美国宾夕法尼亚州拉德诺的生物技术、化工及制药领域企业，前身为1904年成立的J.T. Baker，2010年正式更名，2019年在纽约证券交易所挂牌上市，股票代码为AVTR，为全球生命科学、医疗健康等行业客户提供核心产品与服务。
Rocket Companies, Inc.是美国金融科技及住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
AVTR vs RKT — 直观对比
营收规模更大
RKT
是对方的1.6倍
$1.7B
营收增速更快
RKT
高出53.5%
-1.4%
净利率更高
AVTR
高出0.6%
2.5%
自由现金流更多
AVTR
多$1.4B
$-1.3B
两年增速更快
RKT
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $2.7B |
| 净利润 | $52.4M | $68.0M |
| 毛利率 | 31.5% | — |
| 营业利润率 | 7.6% | 6.3% |
| 净利率 | 3.1% | 2.5% |
| 营收同比 | -1.4% | 52.2% |
| 净利润同比 | -89.5% | 100.8% |
| 每股收益（稀释后） | $0.08 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVTRRKT
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.6B | $1.6B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.6B | $1.0B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.7B | $646.9M | ||
| Q2 24 | $1.7B | $1.3B | ||
| Q1 24 | $1.7B | $1.4B |
净利润AVTRRKT
| Q4 25 | $52.4M | $68.0M | ||
| Q3 25 | $-711.8M | $-123.9M | ||
| Q2 25 | $64.7M | $-1.8M | ||
| Q1 25 | $64.5M | $-10.4M | ||
| Q4 24 | $500.4M | $33.9M | ||
| Q3 24 | $57.8M | $-22.0M | ||
| Q2 24 | $92.9M | $1.3M | ||
| Q1 24 | $60.4M | $16.2M |
毛利率AVTRRKT
| Q4 25 | 31.5% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 33.8% | — | ||
| Q4 24 | 33.4% | 58.9% | ||
| Q3 24 | 32.9% | -8.4% | ||
| Q2 24 | 34.1% | 47.4% | ||
| Q1 24 | 34.0% | 51.2% |
营业利润率AVTRRKT
| Q4 25 | 7.6% | 6.3% | ||
| Q3 25 | -40.0% | -11.5% | ||
| Q2 25 | 7.7% | 1.8% | ||
| Q1 25 | 9.3% | -21.5% | ||
| Q4 24 | 37.8% | 38.1% | ||
| Q3 24 | 7.3% | -76.9% | ||
| Q2 24 | 10.3% | 14.8% | ||
| Q1 24 | 8.7% | 21.6% |
净利率AVTRRKT
| Q4 25 | 3.1% | 2.5% | ||
| Q3 25 | -43.8% | -7.7% | ||
| Q2 25 | 3.8% | -0.1% | ||
| Q1 25 | 4.1% | -1.0% | ||
| Q4 24 | 29.7% | 1.9% | ||
| Q3 24 | 3.4% | -3.4% | ||
| Q2 24 | 5.5% | 0.1% | ||
| Q1 24 | 3.6% | 1.2% |
每股收益（稀释后）AVTRRKT
| Q4 25 | $0.08 | $0.10 | ||
| Q3 25 | $-1.04 | $-0.06 | ||
| Q2 25 | $0.09 | $-0.01 | ||
| Q1 25 | $0.09 | $-0.08 | ||
| Q4 24 | $0.73 | $0.28 | ||
| Q3 24 | $0.08 | $-0.19 | ||
| Q2 24 | $0.14 | $0.01 | ||
| Q1 24 | $0.09 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $365.4M | $2.7B |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $5.6B | $22.9B |
| 总资产 | $11.8B | $60.7B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
现金及短期投资AVTRRKT
| Q4 25 | $365.4M | $2.7B | ||
| Q3 25 | $251.9M | $5.8B | ||
| Q2 25 | $449.4M | $5.1B | ||
| Q1 25 | $315.7M | $1.4B | ||
| Q4 24 | $261.9M | $1.3B | ||
| Q3 24 | $285.3M | $1.2B | ||
| Q2 24 | $272.6M | $1.3B | ||
| Q1 24 | $234.9M | $861.4M |
总债务AVTRRKT
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $5.1B | — | ||
| Q1 24 | $5.3B | — |
股东权益AVTRRKT
| Q4 25 | $5.6B | $22.9B | ||
| Q3 25 | $5.6B | $8.9B | ||
| Q2 25 | $6.3B | $7.4B | ||
| Q1 25 | $6.1B | $8.6B | ||
| Q4 24 | $6.0B | $9.0B | ||
| Q3 24 | $5.6B | $8.4B | ||
| Q2 24 | $5.4B | $8.8B | ||
| Q1 24 | $5.3B | $8.6B |
总资产AVTRRKT
| Q4 25 | $11.8B | $60.7B | ||
| Q3 25 | $11.7B | $33.6B | ||
| Q2 25 | $12.8B | $30.4B | ||
| Q1 25 | $12.3B | $25.3B | ||
| Q4 24 | $12.1B | $24.5B | ||
| Q3 24 | $12.8B | $25.1B | ||
| Q2 24 | $12.7B | $23.6B | ||
| Q1 24 | $12.8B | $22.2B |
负债/权益比AVTRRKT
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 1.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.7M | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | $117.2M | $-1.3B |
| 自由现金流率自由现金流/营收 | 7.0% | -47.2% |
| 资本支出强度资本支出/营收 | 2.1% | 1.5% |
| 现金转化率经营现金流/净利润 | 2.91× | -18.08× |
| 过去12个月自由现金流最近4个季度 | $495.0M | $-4.0B |
8季度趋势，按日历期对齐
经营现金流AVTRRKT
| Q4 25 | $152.7M | $-1.2B | ||
| Q3 25 | $207.4M | $-50.3M | ||
| Q2 25 | $154.4M | $-1.9B | ||
| Q1 25 | $109.3M | $-797.0M | ||
| Q4 24 | $173.3M | $1.8B | ||
| Q3 24 | $244.8M | $-1.3B | ||
| Q2 24 | $281.1M | $-122.3M | ||
| Q1 24 | $141.6M | $-3.0B |
自由现金流AVTRRKT
| Q4 25 | $117.2M | $-1.3B | ||
| Q3 25 | $171.7M | $-71.8M | ||
| Q2 25 | $124.8M | $-1.9B | ||
| Q1 25 | $81.3M | $-811.0M | ||
| Q4 24 | $145.8M | $1.8B | ||
| Q3 24 | $204.0M | $-1.4B | ||
| Q2 24 | $235.3M | $-138.3M | ||
| Q1 24 | $106.9M | $-3.0B |
自由现金流率AVTRRKT
| Q4 25 | 7.0% | -47.2% | ||
| Q3 25 | 10.6% | -4.5% | ||
| Q2 25 | 7.4% | -137.2% | ||
| Q1 25 | 5.1% | -78.2% | ||
| Q4 24 | 8.6% | 103.1% | ||
| Q3 24 | 11.9% | -209.6% | ||
| Q2 24 | 13.8% | -10.6% | ||
| Q1 24 | 6.4% | -218.7% |
资本支出强度AVTRRKT
| Q4 25 | 2.1% | 1.5% | ||
| Q3 25 | 2.2% | 1.3% | ||
| Q2 25 | 1.8% | 1.1% | ||
| Q1 25 | 1.8% | 1.4% | ||
| Q4 24 | 1.6% | 1.1% | ||
| Q3 24 | 2.4% | 2.9% | ||
| Q2 24 | 2.7% | 1.2% | ||
| Q1 24 | 2.1% | 1.0% |
现金转化率AVTRRKT
| Q4 25 | 2.91× | -18.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.39× | — | ||
| Q1 25 | 1.69× | — | ||
| Q4 24 | 0.35× | 54.42× | ||
| Q3 24 | 4.24× | — | ||
| Q2 24 | 3.03× | -94.46× | ||
| Q1 24 | 2.34× | -185.80× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |
